Artificial Intelligence Eye Screening Software Market Set to Surge - Key Insights You Must Know

Artificial Intelligence Eye Screening Software Market Size

The global Artificial Intelligence Eye Screening Software market was valued at US$ 115 million in 2023 and is anticipated to reach US$ 8808 million by 2030, witnessing a CAGR of 84.0% during the forecast period 2024-2030.

Artificial intelligence (AI) is becoming established as a new method for analysing ophthalmological data, and unveiling new clinical and pathogenic insights into retinal diseases. AI-based algorithms are largely employed in the field of the most prevalent retinal diseases, including diabetic retinopathy, age-related macular degeneration and myopia.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-10P17096/Global_Artificial_Intelligence_Eye_Screening_Software_Market_Research_Report_2024

Diabetes continues to rise throughout the United States and worldwide. Estimates show that the prevalence of diabetes mellitus will rise to 578 million people (10.2%) by the year 2030 and 700 million people (10.9%) by the year 2045. This increase in the prevalence of diabetes can also lead to a corresponding increase in diabetic complications, including nephropathy, cardiovascular disease, neuropathy, and retinopathy. It is estimated that vision-threatening diabetic retinopathy (vtDR) is present in around 22% of patients with diabetes, with clinically significant macular edema present in about 4% of patients, although the numbers can widely vary based on the population and access to care. Regardless of the exact numbers, there is no doubt that diabetic retinopathy remains a significant health burden and cause of visual loss. Early detection of diabetic retinopathy is key, because early treatment and lifestyle modifications can help prevent or minimize vision-threatening complications.

This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence Eye Screening Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence Eye Screening Software.

The Artificial Intelligence Eye Screening Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Intelligence Eye Screening Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

By Type
• Diabetic Retinopathy (DR)
• Age-Related Macular Degeneration (AMD)
• Myopia

By Application
• Medical Institutions
• Great Health Scene

Key Companies
Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), Vistel, RETINA-AI Health, Acer Medical

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-10P17096/global-artificial-intelligence-eye-screening-software

Email Id:
Please reach us at sales@valuates.com

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains detail research methodology employed to generate the report, Please also reach to our sales team to get the complete list of our data sources

This release was published on openPR.